Neuros Medical Receives FDA Breakthrough Device Designation for its Novel Altius® High Frequency Nerve Block System

June 29, 2021

Read More ›

4D Molecular Therapeutics Announces Rare Disease Ophthalmology Product Candidate Portfolio Update, Including Initial Clinical Safety and Tolerability Data for 4D-110 for Choroideremia and 4D-125 for XLRP, and Termination of Roche Collaboration and License

June 24, 2021

Read More ›

Monte Rosa Therapeutics Announces Pricing of Initial Public Offering

June 24, 2021

Read More ›

Antios Therapeutics’ ATI-2173 Demonstrates Potent Antiviral Activity and Evidence of Off-Treatment Sustained Viral Suppression in Chronic HBV Patients

June 23, 2021

Read More ›

Contego Medical, Inc. announced receipt of CE Mark approval for the Neuroguard IEP®

April 16, 2021

Read More ›

Impulse Dynamics Receives Approval to Sell Optimizer CCM Devices in China

February 22, 2021

Read More ›

Impulse Dynamics Announces FDA Approval for Magnetic Resonance Imaging

January 20, 2021

Read More ›

Impulse Dynamics Closes $60 Million Financing

January 12, 2021

Read More ›

Neuros Medical Announces Key Milestones in the QUEST Pivotal Clinical Study for Chronic Post-Amputation Pain

January 7, 2021

Read More ›